ADC Therapeutics S.A.

General ticker "ADCT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $286.8M (TTM average)

ADC Therapeutics S.A. follows the US Stock Market performance with the rate: 57.6%.

Estimated limits based on current volatility of 6.1%: low 4.16$, high 4.70$

Factors to consider:

  • Total employees count: 274 as of 2023
  • US accounted for 99.3% of revenue in the fiscal year ended 2023-12-31
  • Top business risk factors: Product liability, Operational and conduct risks, Regulatory and compliance, Supply chain disruptions, Manufacturing risks
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [2.55$, 6.83$]
  • 2026-12-31 to 2027-12-31 estimated range: [2.44$, 6.51$]

Similar symbols

Short-term ADCT quotes

Long-term ADCT plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $69.56MM $70.84MM $81.36MM
Operating Expenses $235.54MM $201.49MM $189.74MM
Operating Income $-165.99MM $-130.65MM $-108.38MM
Non-Operating Income $-29.43MM $-27.03MM $-34.40MM
Interest Expense $46.33MM $50.21MM $51.63MM
R&D Expense $127.13MM $109.63MM $104.00MM
Income(Loss) $-195.42MM $-157.68MM $-142.78MM
Taxes $39.11MM $0.17MM $-0.16MM
Other Income(Loss) $-5.53MM $0.00MM $0.00MM
Profit(Loss)* $-240.05MM $-157.85MM $-142.62MM
Stockholders Equity $-148.25MM $-202.64MM $-185.83MM
Inventory $16.18MM $18.39MM $4.18MM
Assets $354.78MM $321.98MM $323.15MM
Operating Cash Flow $-118.69MM $-123.83MM $-141.17MM
Capital expenditure $3.22MM $0.87MM $0.26MM
Investing Cash Flow $-3.22MM $-0.87MM $0.40MM
Financing Cash Flow $73.88MM $97.05MM $150.94MM
Earnings Per Share** $-2.94 $-1.62 $-1.12

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.